Medpal Ai annual return on equity
2023
2025
Medpal Ai Return on Equity (ROE) Growth & History (MPAL)
Medpal Ai's return on equity was −581.35% for fiscal 2025.
View full Medpal Ai company overviewMedpal Ai annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-08-31 | −581.35% | — |
| 2023 | 2023-08-31 | −911.37% | — |
Medpal Ai return on equity trends
Between the periods ended 2023-08-31 and 2025-08-31, Medpal Ai's return on equity increased from −911.37% to −581.35%, a change of +330.03 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medpal Ai source filings ↗Community posts
MedPal reports £1.83m of August New Health revenue; £28m annualised figure is not a forecast
MedPal AI published an August trading update on 7 September 2026. Reported activity New Health generated £1,828,319 revenue from 14,487 orders in August, its first full month of trading after marketing began in July. That compares with £201 ...